REDX IMMUNOLOGY LIMITED
09000503Research and experimental development on biotechnology
REDX IMMUNOLOGY LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Block 33 Mereside Alderley Park Macclesfield SK10 4TG England
Full company profile for REDX IMMUNOLOGY LIMITED (09000503), an active life sciences and medical technology company based in Macclesfield, England. Incorporated 16 Apr 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2015–2024)
Cash in Bank
£202.55k
Net Assets
-£59.14M
Total Liabilities
£62.40M
Turnover
£186.82k
Employees
3
Debt Ratio
1917%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 30 Sept Year End | 2023 30 Sept Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Anson, Lisa Mary Whewell | Director | British | England | 7 Feb 2020 | Active |
| Collum, Peter | Director | American | United States | 29 May 2025 | Active |
See all 11 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Redx Pharma Limited
United Kingdom
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Neil David Murray
Ceased 3 Nov 2017
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 8 Jun 2026 | Accounts | Annual accounts made up to 30 Sept 2025 | |
| 20 Apr 2026 | Confirmation Statement | Confirmation statement made on 16 Apr 2026 with updates | |
| 19 Apr 2026 | Mortgage | Mortgage Create With Deed With Charge Number Charge Creation Date | |
| 2 Oct 2025 | Officers | Appointment of Mr Andrew William Booth as director on 1 Oct 2025 | |
| 1 Oct 2025 | Officers | Termination of Claire Penelope Solk as director on 30 Sept 2025 |
Annual accounts made up to 30 Sept 2025
Confirmation statement made on 16 Apr 2026 with updates
Mortgage Create With Deed With Charge Number Charge Creation Date
Appointment of Mr Andrew William Booth as director on 1 Oct 2025
Termination of Claire Penelope Solk as director on 30 Sept 2025
Recent Activity
Latest Activity
Annual accounts made up to 30 Sept 2025
2 weeks ago on 8 Jun 2026
Confirmation statement made on 16 Apr 2026 with updates
2 months ago on 20 Apr 2026
Mortgage Create With Deed With Charge Number Charge Creation Date
2 months ago on 19 Apr 2026
Appointment of Mr Andrew William Booth as director on 1 Oct 2025
8 months ago on 2 Oct 2025
Termination of Claire Penelope Solk as director on 30 Sept 2025
8 months ago on 1 Oct 2025